34 related articles for article (PubMed ID: 21920737)
1. Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.
Hu T; Prabhakaran M; Acharya SA; Manjula BN
Biochem J; 2005 Dec; 392(Pt 3):555-64. PubMed ID: 16111474
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide.
Pinto S; Hosseini M; Buckley ST; Yin W; Garousi J; Gräslund T; van Ijzendoorn S; Santos HA; Sarmento B
J Control Release; 2024 Feb; 366():621-636. PubMed ID: 38215986
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Conjugation Yield of Brush Polymer-Protein Conjugates by Increasing Linker Length at the Polymer End-Group.
Nauka PC; Lee J; Maynard HD
Polym Chem; 2016 Apr; 7(13):2352-2357. PubMed ID: 27110293
[TBL] [Abstract][Full Text] [Related]
4. Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides.
Hameedat F; Pinto S; Marques J; Dias S; Sarmento B
Drug Deliv Transl Res; 2023 Jun; 13(6):1699-1715. PubMed ID: 36587110
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Stable Cholesteryl-Polyethylene Glycol-Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths.
Cristóbal-Lecina E; Pulido D; Martin-Malpartida P; Macias MJ; Albericio F; Royo M
ACS Omega; 2020 Mar; 5(10):5508-5519. PubMed ID: 32201843
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules.
Cavaco M; Frutos S; Oliete P; Valle J; Andreu D; Castanho MARB; Vila-Perelló M; Neves V
ACS Med Chem Lett; 2021 Nov; 12(11):1663-1668. PubMed ID: 36060671
[TBL] [Abstract][Full Text] [Related]
7. Peptibodies: An elegant solution for a long-standing problem.
Cavaco M; Castanho MARB; Neves V
Biopolymers; 2017 Dec; ():. PubMed ID: 29266205
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptides from Amphibian Innate Immune System as Potent Antidiabetic Agents: A Literature Review and Bioinformatics Analysis.
Soltaninejad H; Zare-Zardini H; Ordooei M; Ghelmani Y; Ghadiri-Anari A; Mojahedi S; Hamidieh AA
J Diabetes Res; 2021; 2021():2894722. PubMed ID: 34307688
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides.
Amatya R; Park T; Hwang S; Yang J; Lee Y; Cheong H; Moon C; Kwak HD; Min KA; Shin MC
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397648
[TBL] [Abstract][Full Text] [Related]
10. Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.
Stöppler D; Macpherson A; Smith-Penzel S; Basse N; Lecomte F; Deboves H; Taylor RD; Norman T; Porter J; Waters LC; Westwood M; Cossins B; Cain K; White J; Griffin R; Prosser C; Kelm S; Sullivan AH; Fox D; Carr MD; Henry A; Taylor R; Meier BH; Oschkinat H; Lawson AD
PLoS Biol; 2018 May; 16(5):e2006192. PubMed ID: 29782488
[TBL] [Abstract][Full Text] [Related]
11. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.
Petkova SB; Akilesh S; Sproule TJ; Christianson GJ; Al Khabbaz H; Brown AC; Presta LG; Meng YG; Roopenian DC
Int Immunol; 2006 Dec; 18(12):1759-69. PubMed ID: 17077181
[TBL] [Abstract][Full Text] [Related]
12. Protein-polymer conjugation-moving beyond PEGylation.
Qi Y; Chilkoti A
Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
[TBL] [Abstract][Full Text] [Related]
13. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques.
Francis GE; Fisher D; Delgado C; Malik F; Gardiner A; Neale D
Int J Hematol; 1998 Jul; 68(1):1-18. PubMed ID: 9713164
[TBL] [Abstract][Full Text] [Related]
14. PEGylation enhances the therapeutic potential of peptide antagonists of the neonatal Fc receptor, FcRn.
Mezo AR; Low SC; Hoehn T; Palmieri H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6332-5. PubMed ID: 21920737
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of dimeric peptide antagonists of the human immunoglobulin G-human neonatal Fc receptor (IgG-FcRn) interaction.
McDonnell KA; Low SC; Hoehn T; Donnelly R; Palmieri H; Fraley C; Sakorafas P; Mezo AR
J Med Chem; 2010 Feb; 53(4):1587-96. PubMed ID: 20092334
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction.
Mezo AR; McDonnell KA; Castro A; Fraley C
Bioorg Med Chem; 2008 Jun; 16(12):6394-405. PubMed ID: 18501614
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
